Prescriptive Reference Standards of Third-Trimester Cerebroplacental Ratio and Its Physiological Determinants.

Cerebroplacental ratio Color Doppler ultrasonography Doppler ultrasound Fetal growth restriction Normality ranges

Journal

Fetal diagnosis and therapy
ISSN: 1421-9964
Titre abrégé: Fetal Diagn Ther
Pays: Switzerland
ID NLM: 9107463

Informations de publication

Date de publication:
14 Jul 2020
Historique:
received: 20 11 2019
accepted: 26 04 2020
entrez: 15 7 2020
pubmed: 15 7 2020
medline: 15 7 2020
Statut: aheadofprint

Résumé

To construct valid reference standards reflecting optimal cerebroplacental ratio and to explore its physiological determinants. A cohort of 391 low-risk pregnancies of singleton pregnancies of nonmalformed fetuses without maternal medical conditions and with normal perinatal outcomes was created. Doppler measurements of the middle cerebral artery and umbilical artery were performed at 24-42 weeks. Reference standards were produced, and the influence of physiological determinants was explored by nonparametric quantile regression. The derived standards were validated in a cohort of 200 low-risk pregnancies. Maternal body mass index was significantly associated with the 5th centile of the cerebroplacental ratio. For each additional unit of body mass index, the 5th centile was on average 0.014 lower. The derived 5th, 10th, and 50th centiles selected in the validation cohort were 5, 9.5, and 51% of the measurements. This study provides methodologically sound prescriptive standards and suggests that maternal body mass index is a determinant of a cutoff commonly used for decision-making.

Identifiants

pubmed: 32663828
pii: 000508366
doi: 10.1159/000508366
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-8

Commentaires et corrections

Type : ErratumIn

Informations de copyright

© 2020 S. Karger AG, Basel.

Auteurs

Marta Rial-Crestelo (M)

Hospital Clinic Barcelona, Fetal Medicine Unit, Fetal Medicine Research Center, BCNatal-Barcelona Center for Maternal-Fetal and Neonatal Medicine (Hospital Clínic and Hospital San Joan de Deu), Barcelona, Spain.

Laura Garcia-Otero (L)

Fetal Medicine Unit Fetal Medicine Research Center, BCNatal-Barcelona Center for Maternal-Fetal and Neonatal Medicine (Hospital Clínic and Hospital San Joan de Deu), Barcelona, Spain.

Annalisa Cancemi (A)

Fetal Medicine Unit Fetal Medicine Research Center, BCNatal-Barcelona Center for Maternal-Fetal and Neonatal Medicine (Hospital Clínic and Hospital San Joan de Deu), Barcelona, Spain.

Mariella Giannone (M)

Fetal Medicine Unit Fetal Medicine Research Center, BCNatal-Barcelona Center for Maternal-Fetal and Neonatal Medicine (Hospital Clínic and Hospital San Joan de Deu), Barcelona, Spain.

Elena Escazzocchio (E)

Atenció a la Salut Sexual i Reproductiva (ASSIR) de Barcelona ciutat, Institut Catala de la Salut, Barcelona, Spain.

Alex Biterna (A)

Obstetrics and Gynecology Institut Catala de la Salut, Atencio Primaria Barcelona Ciutat, Barcelona, Spain.

Elena Ferriols (E)

Obstetrics and Gynecology Consorci Parc de Salut Mar, Hospital del Mar, Barcelona, Spain.

Jose Luis Hernandez (JL)

Obstetrics and Gynecology Consorci Parc de Salut Mar, Hospital del Mar, Barcelona, Spain.

Marek Lubusky (M)

Department of Obstetrics and Gynecology, Palacky University Olomouc, Faculty of Medicine and Dentistry, University Hospital Olomouc, Olomouc, Czechia.

Veronika Kolarova (V)

Department of Obstetrics and Gynecology, Palacky University Olomouc, Faculty of Medicine and Dentistry, University Hospital Olomouc, Olomouc, Czechia.

Ladislav Krofta (L)

Obstetrics and Gynecology, Institute for the Care of Mother and Child, Prague, Czechia.

Jiri Vojtêch (J)

Center of Fetal Medicine, Institute for the Care of Mother and Child, Prague, Czechia.

Eyal Zohav (E)

Department of Obstetrics and Gynecology, Affiliated to the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.

Karina Krajden (K)

Wolfson Medical Center, Ultrasound Unit, Fetal Neurology Clinic, Holon, Israel.

Rogelio Cruz-Martinez (R)

Fetal Medicine Research Center, Fetal Medicine Mexico, Querétaro, Mexico.

Monica Cruz-Lemini (M)

Fetal Medicine Research Center, Fetal Medicine Mexico, Querétaro, Mexico.

Mauro Parra-Cordero (M)

Fetal Medicine Unit, Hospital Clínico Universidad de Chile, Santiago de Chile, Chile.

Pamela Socias (P)

Obstetrics and Gynecology Fetal Medicine Unit, University of Chile Hospital, Santiago de Chile, Chile.

Fàtima Crispi (F)

Maternal-Fetal Medicine BCNatal-Barcelona Center for Maternal-Fetal and Neonatal Medicine (Hospitals Clínic and Sant Joan de Déu), IDIBAPS, Barcelona University, Centre for Biomedical Research on Rare Diseases (CIBER-ER), Barcelona, Spain.

Marta Lopez (M)

Hospital Clinic Barcelona, Fetal Medicine Unit, Fetal Medicine Research Center, BCNatal-Barcelona Center for Maternal-Fetal and Neonatal Medicine (Hospital Clínic and Hospital San Joan de Deu), Barcelona, Spain.

Eduard Gratacós (E)

Hospital Clinic Barcelona, Fetal Medicine Unit, Fetal Medicine Research Center, BCNatal-Barcelona Center for Maternal-Fetal and Neonatal Medicine (Hospital Clínic and Hospital San Joan de Deu), Barcelona, Spain.

Francesc Figueras (F)

Hospital Clinic Barcelona, Fetal Medicine Unit, Fetal Medicine Research Center, BCNatal-Barcelona Center for Maternal-Fetal and Neonatal Medicine (Hospital Clínic and Hospital San Joan de Deu), Barcelona, Spain, ffiguera@clinic.cat.

Classifications MeSH